Where do Dyne Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Dyne Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-55.7%+32.3pp	-88%+49.3pp	-137.3%-83.1pp	-54.2%-12.2pp
Return on assets	-47.5%+26.6pp	-74.1%+26.0pp	-100.1%-54.2pp	-45.9%-7.6pp
Return on invested capital	-200.8%—	——	——	-110%+13.8pp
Liquidity
Current ratio	22.3×+6.7×	15.6×+13.1×	2.5×-6.9×	9.5×-3.9×
Quick ratio	22.3×+6.7×	15.6×+13.1×	2.5×-6.9×	9.5×-3.9×
Cash ratio	17.6×+7.3×	10.3×+7.9×	2.4×-3.7×	6.1×-0.9×
Leverage
Debt-to-equity	0.2×+0.1×	0×-0.3×	0.3×+0.2×	0.1×0.0×
Debt-to-assets	0.1×+0.1×	0×-0.1×	0.2×+0.1×	0.1×0.0×
Interest coverage	-75.6×—	——	——	——
Valuation
Market capitalization	$3.22B+34.3%	$2.4B+194%	$816.53M+34.3%	$608.11M-0.9%
Enterprise value	$2.5B+25.7%	$1.99B+175%	$722.32M+54.9%	$466.45M+4.7%
Price / book	3.3×-0.5×	3.8×-5.1×	8.9×+6.5×	2.4×+0.7×
Free cash flow yield	-12.6%-0.3pp	-12.3%+10.8pp	-23.1%+2.6pp	-25.8%-5.7pp
Earnings yield	-13.9%-0.6pp	-13.2%+15.7pp	-28.9%-1.3pp	-27.6%-3.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Dyne Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Dyne Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.